Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion

Thermo Fisher Scientific agreed to sell its microbiology business to Astorg for about $1.08 billion, including cash and a $50 million seller note. The transaction is a portfolio reshaping move rather than a material operational update, and it may have a modest impact on Thermo Fisher’s valuation and strategic focus. No additional financial terms, closing timeline, or earnings implications were provided.

Analysis

Thermo Fisher Scientific agreed to sell its microbiology business to Astorg for about $1.08 billion, including cash and a $50 million seller note. The transaction is a portfolio reshaping move rather than a material operational update, and it may have a modest impact on Thermo Fisher’s valuation and strategic focus. No additional financial terms, closing timeline, or earnings implications were provided.